Reinvention to Address the Clinician Shortage March 8, 2023, 4:12 a.m.
The clinician shortage is unsustainable. A continuous, dynamic reinvention of care delivery is required – a Total Enterprise Reinvention. This reinvention must amplify the combined power of technology and human ingenuity and foster an ability to adapt to change. Change starts by reinventing care so that healthcare workers have better work experiences that leave them happier, healthier and more productive. A human + technology model can improve engagement through AI-enabled omnichannel connections with patients and lessen the burden on clinicians.
Novocure Announces Reimbursement of Optune® for the Treatment of Newly Diagnosed Glioblastoma in France March 6, 2023, 7:08 a.m.
On March 1, 2023 Novocure (NASDAQ:NVCR) reported the reimbursement and availability of Optune together with temozolomide (TMZ) for the treatment of adult patients with newly diagnosed glioblastoma (GBM) in France (Press release, NovoCure, MAR 1, 2023, View Source [SID1234628018]). The order registering Optune on the List of Reimbursable Products and Services (LPPR) provided for in Article L165-1 of the Social Security Code was published in the Official Journal on February 28, 2023 and will become effective March 15, 2023.
Researchers use CAR-T gel to kill leftover cancer cells after surgery March 6, 2023, 7:04 a.m.
Researchers evaluated the safety and efficacy of a mesothelin-targeted CAR-T construct and delivery method against pancreatic ductal adenocarcinoma and triple-negative breast cancer models. The findings suggest the CAR-T-infused gel can prevent tumor recurrence typically caused by residual cancer cells after surgery and do so without wound-healing complications, according to investigators.
Electronic 'Nudges' Boost Flu Shot Uptake in Seniors March 6, 2023, 6:49 a.m.
"I think the concept that the nudge is to plant an idea that leads to an action is pretty much the basis of a lot of these healthcare interventions, which seems like a small way to have a big impact at outcome," Cho noted. "The behavioral science aspect of the nudges are also fascinating to me personally, and I think to a lot of the cardiologists in the audience, about how you actually get people to act. I think it's been a lifelong question for people in general, how do you get people to follow through on an action?"
LimbForge - Customer Stories March 5, 2023, 4:07 p.m.
LimbForge helps clinicians develop 3D-printed prosthetic limbs for amputees in developing countries, creating high-quality, affordable devices that are custom made to fit individual needs. LimbForge’s prosthetics improve the lives of patients, as well as their families and communities. This small nonprofit organization is using digital-design tools and 3D printing to bring prosthetic care to the poorest regions of the world as part of a wave of innovation that’s making advanced manufacturing tools accessible to anyone, anywhere.
Healthcare Innovation Patients Actually Want March 5, 2023, 4:05 p.m.
When we talk about designing inclusive healthcare innovations at Savvy Cooperative, we’re talking about more than just tokenistic casual patient involvement. Generally speaking, any patient input can be better than none, with the caveat that you need to understand the limitations of the sample and research methodology. When it comes to the sampled population, it is crucial to include a diverse set of individuals, especially those from historically excluded communities, if we hope to create more parity, access, and impact for all patients.
Leveraging Edge Computing to Drive Healthcare Innovation March 5, 2023, 4:02 p.m.
Edge computing is an innovative distributed system that helps to move enterprise applications closer to data sources, such as Internet of Things (IoT) devices or local edge servers. By bringing the applications nearer to where the data originates, there are several rewards: quicker real-time insights, improved reaction times, and amplified bandwidth availability. Adopting edge computing can be enormously beneficial to many stakeholders across the enterprise.
Revolutionizing Medical Treatment: The Rise of Wearable Injectors March 5, 2023, 7:40 a.m.
Wearable injectors are medical devices used to deliver drugs and other therapeutic agents through skin or mucosal membranes. The growth of the wearable injectors market is driven by factors such as the rising prevalence of chronic diseases, increasing focus on patient adherence and convenience, and technological advancements in drug delivery devices. However, the high cost of wearable injectors may restrain the growth of the market to a certain extent.
CAR-T safe, effective for adults with multiple myeloma and renal insufficiency March 5, 2023, 7:31 a.m.
A single dose of the chimeric antigen receptor T-cell therapy presents no additional risk for treatment-related toxicities among patients with renal insufficiency, findings presented at Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR showed.
A Global Turning Point for Cancer CAR T-Cell Therapy March 5, 2023, 7:29 a.m.
With the approval of the first CAR T-cell therapy “Kymriah” in 2017 by the US Food and Drug Administration (FDA), CAR T-cell therapy has shown potential to revolutionize cancer treatment. This therapy is a type of very intricate and particularized immunotherapy employed for treating cancer, in which a person’s T-cells are genetically modified to possess chimeric antigen receptors (CAR) to fight oncologic cells in the body.
In push to expand its CAR-T therapies to US, China biotech Oricell raises additional $45M – March 5, 2023, 7:28 a.m.
Fol­low­ing a show­ing at AS­CO last year with a GPRC5D-di­rect­ed CAR-T ther­a­py for mul­ti­ple myelo­ma, Ori­cell raised a $120 mil­lion Se­ries B in Ju­ly. The lat­est raise is an ex­ten­sion of that round, and was led by RTW In­vest­ments and Qatar In­vest­ment Au­thor­i­ty, fol­lowed by ex­ist­ing in­vestors Qim­ing Ven­ture Part­ners and C&D Emerg­ing In­dus­try Eq­ui­ty In­vest­ment.
Santé, les thérapies CAR-T, nouvelle frontière dans la lutte contre le cancer March 5, 2023, 7:25 a.m.
Les thérapies CAR-T expérimentales représentent la nouvelle frontière dans la lutte contre le cancer. Le traitement, qui semblait impossible il y a seulement 10 ans, consiste en une autogreffe de cellules immunitaires. Utilisé maintenant il apporte d’excellents résultats (rémissions totales) chez de nombreux patients. La prochaine étape, expliquée de manière simple, c’est la formation de cellules prélevées sur des patients pour s’assurer que les cellules génétiquement modifiées apprennent à tuer leurs propres tumeurs. Maintenant, ils essaient d’avoir ces traitements sans effets secondaires. Lors de la récente réunion scientifique de la Fondation Ramón Areces à Madrid, les dernières nouvelles sur le sujet ont été présentées, des nouvelles qui ressemblent vraiment à de la science-fiction.
Chinese Medtech enterprises going global - 10 interventional device makers to watch March 2, 2023, 10:28 p.m.
The medical devices market continued to generate stellar growth in 2022. With the increasing prevalence of cardiovascular and cerebralvascular disease in China, companies are encouraged to develop and create new innovative solutions. Below, EqualOcean has listed 10 leading interventional medical device companies in vascular or neurology fields with overseas business. We hope this will shed some light on Chinese interventional markets.
Patient adherence – the key to restoring trust in pharma March 2, 2023, 7:34 p.m.
Medication is a staple of modern medicine, with almost 50% of adults in the United States taking at least one prescription medication. Despite this, pharmaceutical companies have not won over public trust. A recent study found that only 48% of participants expressed trust in pharmaceutical companies. This lack of trust in such a crucial industry can lead to decreased compliance, poor treatment adherence, and negative health outcomes for patients.
BD & Biocorp Look to Track Patient Adherence March 2, 2023, 7:33 p.m.
The two companies plan to couple Biocorp’s Injay technology with BD’s UltraSafe Plus Passive Needle Guard used with prefillable syringes. Biocorp’s Injay technology, which is designed to “capture and transmit injection events using Near Field Communication (NFC) technology.
Does precision health sound like futuristic hype? It's not. Here's why it's way more promising than many realize. Feb. 27, 2023, 1:13 p.m.
The ultimate goal of Precision Health is to bring about a world where we use all relevant knowledge to prevent disease before it strikes and cure it decisively if it does. It’s a world in which we enable our bodies to be their best, from the start. I believe Precision Health is the future – and this future is already on our doorstep. Here are three trends that prove Precision Health is no longer theory. It’s becoming fact.
Is Health Sharing an Alternative to Traditional Health Insurance? Feb. 27, 2023, 1:11 p.m.
Healthcare has become increasingly unaffordable for ordinary people in the US. It has started to cost more than house payments in many cases. It should be noted that almost 2 out 3 people who had to declare bankruptcy due to healthcare costs have had health insurance. So what is the point of insurance if it doesn't provide financial security? Adding insult to injury, there are the ever-increasing complexities of premiums, deductibles, copays, networks, out-of-pocket costs. This is why no one has any idea how much a medical visit may end up costing. Health Sharing is an innovative and cost-effective, membership-based solution that is NOT an insurance plan. It is meant to provide assistance in paying for major medical expenses like ER visits, hospitalizations, surgeries, etc
Glooko, Sanofi collaborate for SoloStar Pen Connectivity with New Device SoloSmart Feb. 27, 2023, 1:02 p.m.
SoloSmart is a single piece add-on connected device intended for use with SoloStar and DoubleStar insulin injection pens which records the insulin dose, date and time of injection and allows for visualization of the data in the Glooko app, that patients can share with healthcare professionals for connected care in diabetes management. At this time, SoloSmart is not approved in the US.
New medtech to watch for in 2023: boosting health outcomes Feb. 20, 2023, 7:43 p.m.
As earnings season is upon us, we’re receiving a clearer view of what new medtech could be launching this year in the medical device space.
GSK abandons investment in gene and cell therapy and transfer to small nucleic acid drugs Feb. 20, 2023, 6:07 p.m.
GSK believes that instead of rushing to push “off-the-shelf” CAR-T to the clinic, or fully investing in the strategy of cell therapy for solid tumors , it is better to rely on its expertise in the field of genetics to achieve market success more smoothly.